Johnson & Johnson buy Gustl
Start price
26.03.20
/
50%
€112.48
Target price
04.11.21
-
Performance (%)
23.38%
End price
01.04.21
€138.78
Summary
This prediction ended on 01.04.21 with a price of €138.78. The prediction had a final performance of 23.38%. A total of €2.60 was paid as dividends for this prediction. Gustl has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Johnson & Johnson | -2.961% | -2.961% | -10.455% | 0.162% |
| iShares Core DAX® | -1.785% | -1.250% | 11.664% | 12.714% |
| iShares Nasdaq 100 | -2.154% | 0.300% | 37.531% | 41.653% |
| iShares Nikkei 225® | -4.028% | -3.746% | 17.142% | 0.393% |
| iShares S&P 500 | -1.969% | 0.307% | 25.617% | 40.084% |
Comments by Gustl for this prediction
In the thread Johnson & Johnson diskutieren
Buy Johnson & Johnson